Epichem Update
171101_Epichem Update
171017_Monepantel reformulation project continues to progress
171010_PharmAust secures broad patent in US for non-cancer applications of Monepantel
171003_Two key appointments to bolster PharmAust veterinary drug programs
171026_Appendix 4C – Quarterly Report and Company Update for the period ended 30 September 2017